Overview

EUROFINS CDMO ALPHORA INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering ERIBULIN MESYLATE; TREPROSTINIL SODIUM.

API / Drug Master Files

EUROFINS CDMO ALPHORA INC holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • ERIBULIN MESYLATEActive2019-03-14
  • TREPROSTINIL SODIUMActive2011-12-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EUROFINS CDMO ALPHORA INC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.